Hedge Fund - Visium Asset Management

Visium Asset Management has submitted its 13F filing with the SEC for the reporting period of March 31.

Jacob Gottlieb’s Visium Asset Management, Richard Gerson and Navroz D.

The broad portfolio of Jacob Gottlieb’s Visium Asset Management enjoyed a very strong quarter, with the weighted average returns of its 817 reported positions in companies with market-caps of greater...

Stocks in the biotechnology industry have been very active as of late, with companies' shares registering significant gains.

Jacob Gottlieb's Visium Asset Management has recently revealed its equity positions as of the end of the fourth quarter in a 13F filing with the Securities and Exchange Commission.

Pharmaceuticals and life sciences as a sector is where most of the money from hedge funds seems to be flowing in. However, it’s the sector-specific funds that are making the big purchases.

Two Schedule 13G forms filed with the SEC yesterday called my attention.

Visium Asset Management, managed by Jacob Gottlieb, has boosted its stake in CONMED Corporation (NASDAQ:CNMD). In a new filing with the U.S.

Wright Medical Group Inc (NASDAQ:WMGI)'s stake in Jacob Gottlieb's Visium Asset Management's equity portfolio has been slightly increased, as a new filing with the SEC showed.